Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for Analgesia in Severe Burn Dressing Changes
NCT05603975Unknown
- Sponsor
- Shenzhen Second People's Hospital
- Start
- Dec 2022
- Primary completion
- Apr 2025
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of esketamine in burn injury (2 arms), sponsored by Shenzhen Second People's Hospital. Primary endpoint: Dosage of the remedy fentanyl. Status: unknown.
02
Drugs
esketamine
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT05603975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05603975.